Jushi Holdings Inc. expands and strengthens its presence in

0


signs definitive agreement to acquire operating dispensary in Las Vegas, Nevada

Jushi to expand its authorized retail footprint to 36 locations nationwide1; Establishes a fourth vertically integrated state-level operation

BOCA RATON, Fla., September 29, 2021 (GLOBE NEWSWIRE) – Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated multi-state cannabis operator, has announced that it has entered into a definitive agreement (the “Agreement”) to acquire 100% of the interest of an entity operating an adult and drug retail dispensary under the name of The Apothecary2 in Las Vegas, Nevada (“Apothecarium Nevada”). The acquisition of Apothecarium Nevada, as well as the April 2021 purchase of Franklin Bioscience NV, LLC, licensee to cultivate, process and distribute cannabis for medical and adult purposes, will enable Jushi to grow, process and distribute cannabis for medical and adult purposes. integrate vertically into Nevada, as well as provide significant brand exposure for Jushi’s high-quality product lines, including The Bank, The Lab, Tasteology and Sѐche. It will be the Company’s fourth vertically integrated state, alongside Pennsylvania (through its affiliated subsidiaries), Virginia and Massachusetts.

Management commentary

Jushi CEO, President and Founder Jim Cacioppo said, “The acquisition of Apothecarium Nevada represents an exciting opportunity for Jushi to establish its first retail store in this large, strategic western market. Apothecarium Nevada is well aligned with our premier retail approach and will continue to provide patients and consumers with the same elevated in-store experience they expect from our fellow BEYOND / HELLOs.MT retail outlets. With the expansion of our growing, processing and distribution facility currently underway, the acquisition of Apothecarium Nevada will expand our reach with a convenient location off the Strip in downtown Las Vegas. We look forward to working with the leadership team and talented workforce of Apothecarium Nevada as we further expand our footprint in this high growth, limited license market.

The Nevada Apothecary

Located at 7885 W Sahara Ave # 112, Las Vegas, NV, the Nevada Apothecarium is located approximately 6.5 miles west of the Las Vegas Strip. Las Vegas is one of the top tourist destinations in the United States attracting over 42 million tourists3 every year, making Nevada one of the most popular states for tourism. Las Vegas is an internationally renowned beach resort known for its gambling, entertainment, shopping and nightlife, drawing visitors from all over the world year round. The Nevada Apothecarium is next door to Summerlin, a planned community of nearly 100,000 people that currently prohibits the operation of dispensaries. The dispensary is also located about 20 minutes from popular resorts and attractions, and serves customers in-store and online with convenient curbside pickup and door-to-door delivery. Apothecarium Nevada is also building a drive-thru lane, which is expected to be available to customers later this year.

1 Includes an awarded conditional dispensary license where Jushi owns 49%.
2 The Apothecarium is used under license with a subsidiary of TerrAscend Corp.
3 Source: Las Vegas Convention and Visitors Authority (LVCVA)

About Jushi Holdings Inc.

We are a vertically integrated cannabis company led by a leading management team. In the United States, Jushi is focused on building a multi-state portfolio of branded cannabis assets through opportunistic acquisitions, struggling practices and competitive applications. Jushi strives to maximize shareholder value while delivering high quality products at all levels of the cannabis ecosystem. For more information, please visit jushico.com or our social media channels, Instagram, Facebook, Twitter and LinkedIn.

Forward-looking information and statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of US Private Securities Litigation. Reform Act. of 1995. These forward-looking information and forward-looking statements are not representative of historical facts or information or current conditions, but only represent the Company’s beliefs regarding future events, plans or objectives, many of which, by virtue of their nature, involve estimates, projections, plans, objectives, forecasts and assumptions which may prove to be inaccurate. Accordingly, actual results could differ materially from those expressed by these forward-looking statements and such statements should not be relied upon. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terms such as “plans”, “expects” or “does not expect”, “is expected”, “budget” , “Foreseen”, “considers”, “foresees”, “intends”, “anticipates” or “not foresee”, or “believes”, or variations of these words and expressions or may contain statements that certain actions, events or results “may,” “could”, “would”, “could” or “will be taken”, “will continue”, “will occur” or “will be achieved”. Forward-looking information and forward-looking statements contained in this document may include, without limitation, information regarding expectations regarding Jushi, or Jushi’s ability to successfully achieve business objectives, and expectations for others. factors.

By identifying such information and statements in this manner, the Company is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors which may cause actual results, level of activity, performance or achievements of the Company. be materially different from those expressed or implied by this information and statements. In addition, within the framework of the forward-looking information and statements contained in this press release, the Company has certain expectations and has made certain assumptions. Key factors that could cause actual results to differ materially from those projected in forward-looking information and statements include: Jushi’s ability to successfully and / or on time achieve its business objectives, including with regulators, employees, suppliers, customers and competitors; changes in economic, trade and general political conditions, including changes in financial markets; changes in applicable laws; and compliance with extensive government regulations, as well as other risks and uncertainties which are further described in the Company’s MD&A, Discussion and Analysis for the quarter ended June 30, 2021, and other documents filed with securities and regulatory authorities which are available at www. .sedar.com. If one or more of these risks, uncertainties or other factors materialize, or if the assumptions underlying the forward-looking information or statements prove to be incorrect, actual results may differ materially from those described in this document as intended, planned. , anticipated, raw, estimated or expected.

Although the Company believes that the assumptions and factors used in the preparation, and the expectations contained in, the forward-looking information and statements are reasonable, you should not place undue reliance on such information and statements, and no assurance or warranty can be taken. be given that this forward-looking information and statements will prove to be correct, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and / or forward-looking statements that are contained or referred to. herein, except in accordance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to the Company or to persons acting on its behalf are expressly qualified in their entirety by this notice.

Do not distribute to news agencies in the United States or broadcast in the United States.

For more information, please contact:

Investor Relations Contact:
Michael perlman
Executive Vice President of Investor Relations and Treasury
561-281-0247
[email protected]

Media contact:
Ellen melody
MATTIO Communication
570-209-2947
[email protected]


Share.

Leave A Reply